Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
(tested or 100% immunogen sequence identity)
Western blot (0.1 - 0.2 µg/ml)
Flow Cytometry (50 µg/ml)
ELISA (0.5 - 1 µg/ml)
NS0-derived rmIntegin a9 extracellular domain.
Recognizes mouse Integrin a9. Cross-reactivity: rhIntegrin a1, a8, a9, aL, rmIntegrin 3, 4, 5, E, and M 5%.
Suitable for use in Western Blot, Flow Cytometry and ELISA. Western Blot: 0.1-0.2 ug/ml. Detection limit for rmIntegrin alpha9 is ~5 ng/lane under non-reducing and reducing conditions, respectively. Flow Cytometry: 50 ug/ml. Use 10 ul to 1-2.5x10^5 cells in a total reaction volume not exceeding 200ul. Tested on D3 mouse embryonic stem cells. Direct ELISA: 0.5-1 ug/ml. Detection limit for rmIntegrin alpha9 is ~0.2 ng/well.
Lyophilized from PBS, pH 7.4, 5% Trehalose
500 µl Reconstitute with 500ul sterile PBS
Lyophilized and resuspended forms: store at -20°C.
ITGA9 / Integrin Alpha 9 is an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers.